Objectives-To evaluate the value of multiparametric quantitative ultrasound imaging in assessing chronic kidney disease (CKD) using kidney biopsy pathologic findings as reference standards.
C hronic kidney disease (CKD) is a high-prevalence disorder from which approximately 11.5% of US adults suffer, with much higher rates in certain minority populations and the elderly. 1 The etiology of CKD is complex, and the progression of kidney damage in those patients is dynamic. An increase in the extracellular matrix synthesis, with excessive fibrillary collagens, characterizes the development of chronic lesions in the glomeruli, interstitial compartment, and vascular system of the kidney, which progressively leads to end-stage renal disease and renal failure that needs to be managed with replacement therapy such as dialysis or renal transplantation. 2, 3 The underlying pathophysiologic mechanisms participating in the disease processes of CKD are being increasingly identified, and various experimental models have demonstrated the ability to inhibit fibrosis or promote regression. As such management strategies are implemented in the clinical environment, the incidence of end-stage renal disease can be reduced. 4, 5 Therefore, techniques that are capable of identifying CKD in earlier stages and accurately assessing the effects of treatment are crucial in ultimately retarding the development of end-stage renal disease. [6] [7] [8] Currently, two main methods exist to evaluate and monitor kidney disease. These methods are either too insensitive, such as conventional serum tests (eg, serum creatinine), or too invasive, such as kidney biopsy with potential complications (eg, bleeding). 9 Patients who have serum creatinine levels within the "normal" range may nonetheless have a substantial reduction in kidney function, which can be seen in stage III of CKD. 1, 10 In addition, there are patients who would not meet the criteria for immunotherapy if interstitial fibrosis and scarring are present. Currently, biopsy is the reference standard to determine this condition; however, if it could be accurately detected and monitored by an ultrasound technique, it would prevent the need for an invasive procedure. Therefore, the interest in developing new noninvasive methods for early identification and sensitive quantification of glomerular, interstitial, and vascular disorders in CKD has been continuously increasing.
Among imaging techniques, magnetic resonance imaging can assess corticomedullary differentiation associated with chronic renal parenchymal disorders 11 ; however, it is not suitable for patients who have claustrophobia or a pacemaker. In addition, patients with advanced CKD may be at risk of developing nephrogenic systemic fibrosis if a gadolinium-based contrast agent is administered for contrast-enhanced magnetic resonance imaging. 12 Contrast-enhanced computed tomography exposes patients to radiation and possibly puts the patient at risk of contrast agent-induced nephropathy. 13 Therefore, ultrasound imaging, with advantages of informative value, reproducibility, convenience, and low cost, has been considered as the first imaging of choice in assessing CKD. [14] [15] [16] [17] [18] [19] In a conventional ultrasound examination, grayscale imaging is used to observe the morphologic characteristics, including the size, cortical thickness, and echogenicity, of the kidney, 15, 16 and renal artery spectral Doppler imaging is performed to assess the kidney hemodynamics associated with the alterations in the renal parenchyma and kidney function. [17] [18] [19] [20] Ultrasound elasticity imaging, including ultrasound strain imaging and shear wave elastography, is an imaging technique that estimates tissue biomechanical properties associated with cortical pathologic changes (such as interstitial fibrosis), which are fundamentally linked to kidney function. [21] [22] [23] [24] These technological advances in ultrasound imaging have, however, yet to be validated as quantitative tools for detecting and grading CKD.
The objective of this study was to evaluate the feasibility of multiparametric quantitative ultrasound imaging biomarkers for comprehensively assessing renal cortical morphologic characteristics, hemodynamics, and biomechanical property changes correlated with kidney biopsy pathologic findings in CKD.
Materials and Methods
The Institutional Review Board at Weill Cornell Medicine of Cornell University approved the study (number 1503015995), and all participants provided written informed consent.
Participants
Healthy volunteers who had no history of diabetes, hypertension, proteinuria, trauma, autoimmune disease, or kidney disease of any kind were recruited in the control group. All healthy volunteers had normal kidney function (estimated glomerular filtration rate [GFR] > 60 mL/min/1.73 m 2 ). Individuals scheduled for kidney biopsies as the standard of care for the diagnosis of CKD were recruited into the patient group. Clinical manifestations in patients suspected of having CKD included proteinuria, longterm diabetes, an elevated serum creatinine level, a history of lupus, autoimmune disease, and decreased kidney function (estimated GFR < 60 mL/min/1.73 m 2 ). Based on the study protocol, the estimated GFR was tested before or on the same day as the quantitative ultrasound examination and kidney biopsy were performed. The estimated GFR is calculated by the abbreviated Modification of Diet Renal Disease equation: 175 3 serum creatinine (milligrams per deciliter) -1.154 3 age (years) -0.203 3 0.742 (if female) 3 1.212 (if African American). 1 Ultrasound Imaging Data Acquisition An Acuson S3000 HELX ultrasound system (Siemens Medical Solutions, Mountain View, CA) equipped with a 6C1 (1.5-6.0 MHz) curved linear array transducer was used for acquiring grayscale, spectral Doppler, and Virtual Touch tissue quantification images on acoustic radiation force impulse imaging in patients with CKD immediately before kidney biopsy and in the healthy volunteers.
All participants fasted before the examination, and quantitative ultrasound imaging was performed immediately before kidney biopsies. The participant was placed in the left and right lateral decubitus positions for imaging the right and left kidneys, respectively. The urinary bladder was emptied before the ultrasound examination.
We initiated with a grayscale image. Before scanning, we locked machine settings for acquiring a grayscale image of the kidney. The standardized settings included mechanical index of 1.4, image depth of 12 to 15 cm, scanning frequency of 3.5 MHz, single focus, harmonic imaging, Map E/Space time of 2, total gain, and dynamic range of 65 dB for every examination in all participants. The size of the kidney was expressed by the sagittal length of the kidney. 25 The cortical thickness was the measurement of the anteroposterior dimension of the kidney cortex in the sagittal view. The presence or absence of hydronephrosis, calculi, masses, and perinephric collections was also assessed. A single observer (J.G.) with 30 years of experience in renal ultrasound performed quantitative ultrasound imaging in all patients with CKD and in 10 healthy control participants.
Measuring Renal Parenchyma Pixel Intensity Using ImageJ
A static image of the kidney was stored in the Digital Imaging and Communications in Medicine format and then transferred to a computer, where the renal parenchymal pixel intensity was measured offline with ImageJ (National Institutes of Health, Bethesda, MD; https:// imagej.nih.gov). We measured the pixel intensity by counting 2500 pixels (50 3 50) in a rectangular region of interest (ROI) in the anterior midportion of the kidney cortex where the corticomedullary differentiation was deemed optimal (Figure 1a ). The pixel intensity was measured within renal parenchyma between the kidney capsule and collecting system in the anteroposterior dimension if the corticomedullary differentiation was less well defined (Figure 1b) . With the ImageJ analysis tool, pixel intensity values can be measured and displayed in a histogram (Figure 1 ). Maximum and minimum pixel intensity values represented the highest and lowest pixel counts in the renal parenchymal ROIs. All pixel intensity parameters were measured twice for each kidney. Each pixel intensity parameter used for data analysis was the average of 4 measurements in each participant. Spectral Doppler Parameters of the Renal Arteries Spectral Doppler imaging was performed under color flow imaging guidance to locate the renal arteries. The Doppler gate was 2 to 3 mm. The Doppler angle for sampling arterial flow velocity was corrected by making the direction of the emission sound beam as parallel to the flow direction as possible (at least <308). 26 The Doppler scale and pulse repetition frequency were adjusted to minimize aliasing and maximize the Doppler shift. With electronic calipers, the peak systolic velocity (PSV, centimeters per second), end-diastolic velocity (EDV, centimeters per second), and resistive index (RI) were manually measured within 3 interlobar arteries (adjacent to the medullary pyramids) in the cranial, mid, and caudal portions of the kidney ( Figure 2 ) with the participants holding their breath at end expiration. The RI was automatically calculated with software installed in the scanner [(PSV -EDV)/PSV]. All Doppler parameters were measured twice within the interlobar arteries, for a total of 6 measurements in each kidney. The mean value of the PSV (EDV and RI) was the average of the 12 PSV (EDV and RI) measurements in each participant.
Acoustic Radiation Force Impulse Imaging of the Renal Cortex
The shear wave velocity (SWV, meters per second), a measurement of the shear wave propagation speed, is mathematically proportional to the renal cortical stiffness. 27 The SWV was measured within the anterior parenchyma of the interpolar region of the kidney with Virtual Touch tissue quantification. The kidney capsule and collecting system were excluded. 24 The SWV was measured with a breath-holding maneuver (at the end of expiration). The depth of the ROI for measuring the cortical SWV was 3 to 6 cm from the skin. The size of the ROI for measuring the cortical tissue SWV was fixed at 10 3 5 mm ( Figure 3 ). The measurement was repeated if the SWV value turned out invalid (displayed as XXX/s). In total, 6 valid SWVs were measured in each kidney, and the mean SWV was the average of 12 SWVs in each participant. The mean examination time to acquire all quantitative ultrasound measurements for each participant was approximately 30 minutes.
Kidney Biopsy and Histopathologic Examination
Ultrasound-guided kidney biopsy was performed by a nephrologist using our standard protocol. The patients fasted for 8 to 10 hours before the biopsy. The procedure was performed with each participant in a prone position.
A Siemens Acuson S3000 scanner equipped with a 4V1 sector array transducer and a biopsy guide (UltraPro II needle guide; CIVCO Medical Instruments, Kalona, IA) and a sterile transducer cover provided realtime grayscale images to guide local anesthesia and biopsy. Built-in ultrasound guidance software was used to display the angle and depth of the biopsy needle insertion.
The middle to lower portion of the left kidney was commonly selected for biopsy, and an area lacking prominent vessels on ultrasound imaging was carefully chosen as the biopsy site. An 18-gauge biopsy needle (Bard Peripheral Technologies, Covington, GA) was inserted into the kidney cortex after administration of local anesthesia. With real-time ultrasound guidance, special caution was paid to observe the needle path and obtain adequate biopsy specimens while avoiding damaging the renal vasculature.
The renal biopsy specimens were processed routinely and special stains were used: periodic acid-Schiff, Masson's trichrome, and periodic acid-methenamine silver. The renal parenchyma was systematically examined with particular attention to the glomeruli, tubules, interstitium and arterial vessels. 28 Parameters of chronicity were defined, and the extent of glomerulosclerosis (percent), interstitial fibrosis/tubular atrophy, interstitial inflammation/edema, and degree of arteriosclerosis were estimated to the nearest 5%. The samples were then divided into 4 categories (0, none/normal [ Figure  4a ]; 1, mild [<25%]; 2, moderate [26%-50%]; and 3, severe [>50%; Figure 4b] ). The scoring was based on the Banff scoring for the amount of tubular atrophy and chronic vascular sclerosis. Tubular atrophy was scored in accordance with the criteria for the tubular atrophy score (0, none; 1, 1%-25%; 2, 25%-50%; and 3, 50%), and the amount of vascular sclerosis was scored identically to the criteria for the vascular fibrous initial thickening score (0, none; 1, up to 25% luminal narrowing; 2, 26%-50% luminal narrowing; and 3, 50% luminal narrowing). Since there is no Banff scoring for global glomerulosclerosis, we had to arbitrarily select criteria for that scoring. The interstitial inflammation/edema score was slightly different from the Banff scoring to make it the same as the other parameters, with the only difference being that our grade 0 was none and our grade 1 was 1% to 25%, and the Banff grade 0 is 0% to 10%, and grade 1 is 10% to 25%. 29 We analyzed all of the above 4 chronic renal pathologic parameters involving the glomeruli, interstitial compartment (fibrosis and edema), and arterial vessels because the combination of all kidney pathologic parameters may contribute to the change of renal function and quantitative ultrasound values. All 25 patients with CKD were divided into 2 subgroups based on all pathologic scores: group 1, pathologic mild CKD, for those with no grade 3 and less than 2 of grade 2; and group 2, pathologic moderate to severe CKD, for those with at least 2 of grade 2 or 1 of grade 3.
All kidney biopsy specimens were interpreted by pathologists with more than 30 (Su.S.) and 5 (St.S.) years of experience in interpreting native kidney biopsy pathologic findings who were blinded regarding the results of quantitative ultrasound imaging. However, they were aware of the patients suspected of having CKD.
Statistical Analysis
All variables, including kidney length, cortical thickness, parenchyma pixel intensity, renal artery PSV, EDV, RI, and parenchymal SWV, are expressed as mean 6 standard deviation. Analysis of variance (ANOVA) was used to assess statistical significance of differences in mean quantitative ultrasound measurements between healthy controls and those with mild and moderate CKD. The Bonferroni correction was then applied to test the difference in the paired groups. Pearson correlation coefficients were calculated between quantitative ultrasound parameters and each kidney biopsy pathologic score, between quantitative ultrasound parameters and the estimated GFR, as well as between the total kidney pathologic score and kidney function (estimated GFR 30 The diagnostic performance of each quantitative ultrasound imaging parameter for estimating pathologic moderate to severe CKD and estimated GFR of less than 60 mL/min/1.73 m 2 was estimated by the area under the receiver operating characteristic curve (AUROC).
31 P < .05 was considered a statistically significant difference.
Results
The demographic and clinical information, including etiology, age, sex, body mass index (body weight in kilograms divided by the square of height in meters), pathologic results for the 25 patients with CKD, and demographic information for the 10 healthy controls are listed in Table 1 . Both pathologists evaluated biopsies separately and reached a consensus. There was no difference in pathologic interpretation between the pathologists.
The differences in the PSV, EDV, maximal pixel intensity, minimal pixel intensity, and cortical thickness among healthy controls, mild CKD, and moderate to severe CKD were significant (all P < .01), whereas those for the kidney length, RI, and SWV were not (P > .05; Table 2 ). The PSV, EDV, and cortical thickness were inversely correlated with the kidney pathologic scores (Table 3) , whereas they were positively correlated with the estimated GFR (Table 4) . On the other hand, pixel intensities were correlated positively with the pathologic scores and inversely with the estimated GFR. However, there was no statistically significant correlation of the RI and SWV with pathologic scores (Table 3) or the estimated GFR (Table 4) .
The AUROC, cutoff value, sensitivity, and specificity of quantitative ultrasound parameters for determining pathologic moderate to severe CKD and an estimated GFR of less than 60 mL/min/1.73 m 2 are listed in Table  5 . The PSV and EDV had better diagnostic performance than other quantitative ultrasound parameters for determining moderate to severe CKD by both pathologic scores ( Figure 5 ) and the estimated GFR ( Figure 6 ). The top 2 AUROCs for assessing pathologic moderate to severe CKD and an estimated GFR of less than 60 mL/min/1.73 m 2 were 0.88 and 0.76, respectively, for the PSV, and 0.97 and 0.86 for the EDV (Table 5 ). The estimated GFR was fairly and inversely correlated with age in CKD (r 5 20.47; P 5 .018), whereas it was not with the disease duration (r 5 20.22; P 5 .219).
All quantitative ultrasound imaging parameters, including the SWV, were successfully measured in all participants. The overall rate of repeating the SWV measurement was 20%.
Discussion
It is established that CKD is a pathologic syndrome with variable progression that is frequently characterized by an extended subclinical period. During the progression Based on all scores of 4 kidney biopsy pathologic parameters (glomerulosclerosis, arteriosclerosis, interstitial fibrosis/tubular atrophy, and interstitial inflammation), pathologic mild CKD is for those with no grade 3 and less than 2 of grade 2, and pathologic moderate to severe CKD is for those with at least 2 of grade 2 or 1 of grade 3. a No significant difference in the RI between control and pathologic mild CKD or between pathologic mild CKD and pathologic moderate to severe CKD. Based on all scores of 4 kidney biopsy pathologic parameters (glomerulosclerosis, arteriosclerosis, interstitial fibrosis/tubular atrophy, and interstitial inflammation), pathologic mild CKD is for those with no grade 3 and less than 2 of grade 2, and pathologic moderate to severe CKD is for those with at least 2 of grade 2 or 1 of grade 3.
of CKD, pathologic changes in glomeruli, the interstitial space, and vasculature regions can therefore dynamically alter morphologic characteristics, hemodynamics, and biomechanical properties of the renal parenchyma. However, the means for early detection and precise grading of these pathologic changes in the disease process using eGFR indicates estimated GFR; and M-CKD, pathologic moderate to severe CKD, which is defined as at least 2 of grade 2 or 1 of grade 3 based on all scores for the 4 kidney pathologic parameters.
noninvasive imaging techniques is considered challenging because of the complexity of the etiology and pathologic conditions in CKD. In a small group of patients with CKD, we observed correlations between multiparametric quantitative ultrasound parameters and pathologic findings from renal biopsies. It is not unanticipated that the RI and kidney length weakly correlated with pathologic findings. The RI represents compliance and resistance of the renal arterial vasculature and cannot directly quantify intrarenal blood flow. A decrease in renal length only occurs in the late stages of CKD. 9, 14 We also observed that the PSV and EDV were moderately correlated with interstitial fibrosis/tubular atrophy and arteriosclerosis. Extracellular fibrosis in interstitial fibrosis/tubular atrophy and Figure 5 . Receiver operating characteristic curves for quantitative ultrasound parameters of PSV, EDV, maximal pixel intensity (P.I.Max), and minimal pixel intensity (P.I.Min) (a) and RI, SWV, and cortical thickness (b) for determining pathologic moderate to severe CKD. The cutoff value, sensitivity, and specificity of each parameter for determining pathologic moderate to severe CKD are listed in Table 5 . Figure 6 . Receiver operating characteristic curves for quantitative ultrasound parameters of PSV, EDV, maximal pixel intensity (P.I.Max), and minimal pixel intensity (P.I.Min) (a) and RI, SWV, and cortical thickness (b) for determining CKD with an estimated GFR of less than 60 mL/min/1.73m 2 . The cutoff value, sensitivity, and specificity of each parameter in determining an estimated GFR of less than 60 mL/min/ 1.73m 2 are listed in Table 5 .
lesions in the artery reduce the compliance and distensibility of the arteries and may diminish intrarenal blood flow in both systole and diastole (Figure 2b ). These results are consistent with our previous report describing the changes in the PSV and EDV in lupus nephritis with moderate interstitial fibrosis. 19 Last, we found that the PSV and EDV had a strong inverse correlation with interstitial inflammation/edema. Our results suggest that interstitial inflammation/edema appears to have the strongest effect among all pathologic changes on the reduction of intrarenal blood flow. Theoretically, moderate to severe interstitial inflammation/edema may increase the pressure in the interstitial space, which ultimately limits the distensibility of the renal arteries. Consequentially, reduced intrarenal artery blood flow (perfusion) is a precursor of renal failure in CKD, which is indicated by significant positive correlations of both the PSV and EDV, quantitative measures of intrarenal blood flow for kidney function (estimated GFR) in our study. Among the proposed quantitative ultrasound parameters, two top performance parameters in determining both pathologic moderate to severe CKD and an estimated GFR of less than 60 mL/min/1.73 m 2 were the PSV and EDV.
We also demonstrated that increased pixel intensity was moderately correlated not only with interstitial fibrosis/tubular atrophy and glomerulosclerosis but also with interstitial inflammation/edema (Table 3) . Pixel intensity is a quantitative measure of the echogenicity in grayscale images. A high pixel intensity value represents an ROI that appears hyperechoic (Figure 1b) . Thus, an ultrasound appearance of increased renal parenchymal echogenicity may result from multiple pathologic changes in CKD. In addition, we observed that the kidney parenchymal pixel intensity had a moderately inverse correlation with the estimated GFR (Table 4) . Finally, it is not surprising to note a moderately inverse correlation between the total kidney pathologic score and renal function, as indicated by the estimated GFR (r 5 20.74).
In this study, we did not observe the value of the SWV in determining moderate CKD, although acoustic radiation force impulse imaging, a novel ultrasound elasticity technique in the assessment of liver parenchymal disease, has gained recognition. 32 To date, the role of shear wave elastography for evaluating CKD is still unclear. 24, 33, 34 There are several factors that may contribute to the failure of the SWV in the assessment of CKD. First, compartmentalization, high tissue heterogeneities, and intrinsic tissue anisotropy in kidney parenchyma strongly affect shear wave propagation. Thus, the measured SWV may vary depending on the relationship of the ultrasonic beam to the examined kidney tissue. 21, 23, 34 Therefore, we measured the SWV with the same orientation to avoid issues with anisotropy. Second, the complexity of pathologic changes may limit the value of the SWV in assessing cortical stiffness. Interstitial fibrosis/tubular atrophy and glomerulosclerosis may increase the stiffness of the cortex, which in turn increases the SWV, whereas interstitial inflammation/ edema may decrease the stiffness of the cortex, which in turn decreases the speed of shear wave propagation in the tissue. Furthermore, poor cortical perfusion causing a decrease in the kidney shear wave speed has been reported. 23, 35 Unfortunately, we did not find a statistically significant correlation between the kidney shear wave speed (SWV) and renal blood flow measured by spectral Doppler imaging (PSV and EDV; all P > .05). The reason why our result differed from the published data is not clear. On one hand, decreased renal cortical blood flow is a single factor; however, it is not the only factor affecting the kidney shear wave speed. On the other hand, the effect on the kidney shear wave speed by an acute reduction of kidney perfusion 23 may not be the same as a chronic process of decreasing cortical perfusion in CKD. Nevertheless, the tradeoffs and overlaps among those conditions in CKD may magnify the heterogeneity and tissue anisotropy of renal parenchyma and the complexity of the correlation between kidney disease and the SWV, as well as mask the effect of decreased renal blood flow on the kidney shear wave speed. Therefore, the counterpart pathologic status in such a complex organ may not be fully reflected by a single quantitative ultrasound parameter alone. Finally, the native kidneys are located deep within the retroperitoneum. The SWV cannot be measured in tissue deeper than 8 cm from the skin; therefore, the value of SWV measurement in superficial tissues may differ from that in deeper ones. 34, 36 Fortunately, we were able to measure the SWV at a depth of 3 to 6 cm from the skin in this study.
To our knowledge, this article is the first report to comprehensively analyze the correlations between multiparametric quantitative ultrasound parameters and all kidney pathologic scores in CKD (Table 3 ). In comparison with conventional ultrasound imaging, the proposed multiparametric quantitative ultrasound imaging technique has several advantages. First, pixel intensity estimation can provide quantitative and objective measures of renal parenchymal echogenicity on grayscale images, which overcomes the limits of conventional nonquantitative and subjective observation (in which the difference in the echogenicity between the liver parenchyma and the kidney cortex is interpreted by the observer). Second, quantitative parameters of the interlobar artery PSV and EDV are superior to the RI in the assessment of renal hemodynamics associated with kidney pathologic changes 19 and the estimated GFR. Third, multiparametric quantitative ultrasound parameters have correlations with each individual kidney pathologic change as well as with the sum of changes, and such comprehensive information may improve the sensitivity in diagnosing and monitoring CKD. Finally, the quantitative ultrasound parameters of the PSV, EDV, maximal pixel intensity, and minimal pixel intensity have more significant correlations with kidney pathologic scores than with the estimated GFR. Our results suggest that these quantitative ultrasound parameters seem to have higher diagnostic performance in determining pathologic moderate to severe CKD than assessing an estimated GFR of less than 60 mL/min/1.73 m 2 . It is anticipated that renal function (estimated GFR) has an inverse correlation with age in CKD because the relevance of hypertensive nephrosclerosis with the development of renal failure tends to become higher with age. 1 Lack of a significant correlation between the estimated GFR and disease duration in this report may be the result of the heterogeneous etiology of the CKD group in this study.
There were several limitations in this study. First, the number of participants was small. We were not able to assess the feasibility of staging CKD using the proposed multiparametric quantitative ultrasound imaging because of the sample size. Second, the criteria for classifying pathologic mild and moderate to severe CKD groups in the study may have limitations when interpreting the results, since kidney pathologic changes are complex. It is not unanticipated that a single pathologic parameter may be substantially more dominant than the other 3 or that all 4 parameters may have similar grades. Therefore, further testing the value of multiparametric quantitative ultrasound imaging in assessing CKD using standard criteria for classifying pathologic subgroups and the combination of all pathologic parameters in a large CKD patient population is warranted. Third, a single ultrasound scanner was used in the study. The difference in renal parenchymal pixel intensity, spectral Doppler findings, and SWV values measured by scanners made by different manufactures was thus not tested. Finally, we provide preliminary observations of the value of the proposed multiparametric quantitative ultrasound parameters in determining moderate to severe CKD; however, the feasibility of using those parameters to assess treatment responses in patients with CKD was not investigated. Therefore, a pilot study on using the proposed multiparametric quantitative ultrasound markers in the early diagnosis of subclinical cases, long-term monitoring of disease progression, and assessing treatment responses in CKD should be encouraged.
In conclusion, our results suggest that multiparametric quantitative ultrasound markers may correlate with findings on kidney biopsy and renal function, as indicated by the estimated GFR. Although ultrasound cannot replace kidney biopsy for establishing a clinical diagnosis currently, it may be able to shed light on the chronicity of disease. As a result, ultrasound could be used to determine whether obtaining a biopsy would be helpful at all in changing the management of a particular disease. Interstitial inflammation/edema may have a stronger effect than interstitial fibrosis/tubular atrophy on the changes in intrarenal hemodynamics. The PSV and EDV have high sensitivity and specificity in assessing moderate to severe CKD. The value of the SWV in evaluating CKD needs further investigation. Validating the proposed multiparametric quantitative ultrasound imaging technique in a large CKD patient population is warranted.
